BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 31552587)

  • 21. Stereotactic radiosurgery as the first-line treatment for intracanalicular vestibular schwannomas.
    Ogino A; Lunsford LD; Long H; Johnson S; Faramand A; Niranjan A; Flickinger JC; Kano H
    J Neurosurg; 2021 Feb; 135(4):1051-1057. PubMed ID: 34600434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers.
    Combs SE; Engelhard C; Kopp C; Wiedenmann N; Schramm O; Prokic V; Debus J; Molls M; Grosu AL
    Radiother Oncol; 2015 Mar; 114(3):378-83. PubMed ID: 25702864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: a preliminary report.
    Poen JC; Golby AJ; Forster KM; Martin DP; Chinn DM; Hancock SL; Adler JR
    Neurosurgery; 1999 Dec; 45(6):1299-305; discussion 1305-7. PubMed ID: 10598696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic radiosurgery for Koos grade IV vestibular schwannoma: a multi-institutional study.
    Pikis S; Mantziaris G; Kormath Anand R; Nabeel AM; Sheehan D; Sheehan K; Reda WA; Tawadros SR; Abdelkarim K; El-Shehaby AMN; Emad Eldin R; Peker S; Samanci Y; Kaisman-Elbaz T; Speckter H; Hernández W; Isidor J; Tripathi M; Madan R; Zacharia BE; Daggubati LC; Martínez Moreno N; Martínez Álvarez R; Langlois AM; Mathieu D; Deibert CP; Sudhakar VR; Cifarelli CP; Arteaga Icaza D; Cifarelli DT; Wei Z; Niranjan A; Barnett GH; Lunsford LD; Bowden GN; Sheehan JP
    J Neurosurg; 2023 Feb; 138(2):405-412. PubMed ID: 36303474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline.
    Carlson ML; Jacob JT; Pollock BE; Neff BA; Tombers NM; Driscoll CL; Link MJ
    J Neurosurg; 2013 Mar; 118(3):579-87. PubMed ID: 23101446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma.
    Kano H; Kondziolka D; Khan A; Flickinger JC; Lunsford LD
    J Neurosurg; 2009 Oct; 111(4):863-73. PubMed ID: 19284227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Retrospective Cohort Study of Longitudinal Audiologic Assessment in Single and Fractionated Stereotactic Radiosurgery for Vestibular Schwannoma.
    Khattab MH; Sherry AD; Whitaker R; Wharton DM; Weaver KD; Chambless LB; Cmelak AJ; Attia A
    Neurosurgery; 2019 Dec; 85(6):E1078-E1083. PubMed ID: 31215628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose.
    Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K
    Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hearing subclassification may predict long-term auditory outcomes after radiosurgery for vestibular schwannoma patients with good hearing.
    Mousavi SH; Niranjan A; Akpinar B; Huang M; Kano H; Tonetti D; Flickinger JC; Dade Lunsford L
    J Neurosurg; 2016 Oct; 125(4):845-852. PubMed ID: 26745482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hearing preservation after stereotactic radiosurgery for sporadic intracanalicular vestibular schwannomas classified as Koos grade 1.
    Kang H; Ji SY; Kim CY; Koo JW; Song JJ; Choi BY; Hwang K; Han JH
    Cancer Med; 2024 Jan; 13(2):e6990. PubMed ID: 38348957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five-year outcomes following hypofractionated stereotactic radiotherapy delivered in five fractions for acoustic neuromas: the mean cochlear dose may impact hearing preservation.
    Chen Z; Takehana K; Mizowaki T; Uto M; Ogura K; Sakanaka K; Arakawa Y; Mineharu Y; Miyabe Y; Mukumoto N; Miyamoto S; Hiraoka M
    Int J Clin Oncol; 2018 Aug; 23(4):608-614. PubMed ID: 29556918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Cochlear Dose on Hearing Preservation Following Stereotactic Radiosurgery in Treatment of Vestibular Schwannomas: A Multi-Center Study.
    Chang SD; Muacevic A; Klein AL; Sherman JH; Romanelli P; Santa Maria PL; Fuerweger C; Bossi Zanetti I; Beltramo G; Vaisbush Y; Tran E; Feng A; Teng H; Meola A; Gibbs I; Tolisano AM; Kutz JW; Wardak Z; Nedzi LA; Hong R; MacRae D; Sohal P; Kapoor E; Sabet-Rasekh P; Maghami S; Moncada PX; Zaleski-King A; Amdur R; Monfared A
    World Neurosurg; 2023 Oct; 178():e24-e33. PubMed ID: 37268187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of hearing outcomes following low-dose stereotactic radiosurgery in patients with vestibular schwannomas: A retrospective cohort review.
    Lin RH; Wang TC; Lin CD; Lin HL; Chung HK; Wang CY; Tsou YA; Tsai MH
    Clin Neurol Neurosurg; 2017 Nov; 162():16-21. PubMed ID: 28892717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment Outcomes and Dose Rate Effects Following Gamma Knife Stereotactic Radiosurgery for Vestibular Schwannomas.
    Smith DR; Saadatmand HJ; Wu CC; Black PJ; Wuu YR; Lesser J; Horan M; Isaacson SR; Wang TJC; Sisti MB
    Neurosurgery; 2019 Dec; 85(6):E1084-E1094. PubMed ID: 31270543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature.
    Wagner J; Welzel T; Habermehl D; Debus J; Combs SE
    Tumori; 2014; 100(2):189-94. PubMed ID: 24852864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.
    Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma : Hearing preservation and patients' self-reported outcome based on an established questionnaire.
    Kessel KA; Fischer H; Vogel MM; Oechsner M; Bier H; Meyer B; Combs SE
    Strahlenther Onkol; 2017 Mar; 193(3):192-199. PubMed ID: 27803960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cochlear implantation after radiosurgery for vestibular schwannoma.
    Patel NS; Carlson ML; Link MJ; Neff BA; Van Gompel JJ; Driscoll CLW
    J Neurosurg; 2021 Jul; 135(1):126-135. PubMed ID: 34250789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long term results of primary radiosurgery for vestibular schwannomas.
    Johnson S; Kano H; Faramand A; Pease M; Nakamura A; Hassib M; Spencer D; Sisterson N; Faraji AH; Arai Y; Monaco E; Niranjan A; Flickinger JC; Lunsford LD
    J Neurooncol; 2019 Nov; 145(2):247-255. PubMed ID: 31535315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modern Hearing Preservation Outcomes After Vestibular Schwannoma Stereotactic Radiosurgery.
    Berger A; Alzate JD; Bernstein K; Mullen R; McMenomey S; Jethanemest D; Friedmann DR; Smouha E; Sulman EP; Silverman JS; Roland JT; Golfinos JG; Kondziolka D
    Neurosurgery; 2022 Oct; 91(4):648-657. PubMed ID: 35973088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.